NGEN compared with CLNN: revenue, margins and what each company keeps, and the suppliers and customers both name

NGENNervgen Pharma Corp.

Mkt capRevenueRevenue

CLNNClene Inc.

Mkt capRevenueRevenue

Compare

NGENNervgen Pharma Corp.

CLNNClene Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

NGEN, solidCLNN, dashed

Supply-chain overlap

Revenue flow

NGEN: latest quarter not drawable. CLNN: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NGEN 0

None

Shared 0

No disclosed counterparties: NGEN.

Only CLNN 12

—George Washington Universityunlistedsupplier

—Johns Hopkins Universityunlistedsupplier

—Northwestern Universityunlistedsupplier

—University of Cambridgeunlistedsupplier

8 more · CLNN chain ›

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

NGENNervgen Pharma Corp.

1.37▼−4.86%· post 1.48

Mkt cap$99.1MRevenue—Revenue—

CLNNClene Inc.

3.89▼−0.30%· post 3.89

ClosedOct 30 '26

Mkt cap$49.2MRevenue$90,000Q2 FY26Revenue$342,000FY24

Compare

ClosedOct 30 '26

NGENNervgen Pharma Corp.

CLNNClene Inc.

1.37▼−4.86%post 1.48

Price

3.89▼−0.30%post 3.89

$99.1M

Mkt cap

$49.2M

—

Revenue

$90,000Q2 FY26

—

Revenue

$342,000FY24

NGEN1.37▼−4.86%vsCLNN3.89▼−0.30%ClosedOct 30 '26